Company intelligence / Profile preview

Xi'an Lijun Jinghua Pharmaceutical

Xi'an, Shaanxi, China

Ownership: Private
Development stage: Other

Overview

Xi'an Lijun Jinghua Pharmaceutical is a Chinese pharmaceutical company based in Xi'an, Shaanxi Province, and is a key subsidiary of the Lijun Group. The company specializes in the research, development, and large-scale manufacturing of finished dosage forms, including tablets, capsules, and granules. Its product portfolio primarily focuses on anti-infectives, particularly macrolide and quinolone antibiotics, as well as treatments for respiratory and cardiovascular conditions. As a GMP-certified manufacturer, the company serves both domestic and international markets with a range of essential medicines and generic drugs.

Therapeutic areas: ImmunologyNeurologyInfectious Diseases
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Xi'an Lijun Jinghua Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xi'an Lijun Jinghua Pharmaceutical.

Explore the full profile